Galadima, M.; Teles, M.; Pastor, J.; Hernández-Losa, J.; RodrÃguez-Gil, J.E.; Rivera del Alamo, M.M.
Programmed Death-Ligand (PD-L1), Epidermal Growth Factor (EGF), Relaxin, and Matrix Metalloproteinase-3 (MMP3): Potential Biomarkers of Malignancy in Canine Mammary Neoplasia. Int. J. Mol. Sci. 2024, 25, 1170.
https://doi.org/10.3390/ijms25021170
AMA Style
Galadima M, Teles M, Pastor J, Hernández-Losa J, RodrÃguez-Gil JE, Rivera del Alamo MM.
Programmed Death-Ligand (PD-L1), Epidermal Growth Factor (EGF), Relaxin, and Matrix Metalloproteinase-3 (MMP3): Potential Biomarkers of Malignancy in Canine Mammary Neoplasia. International Journal of Molecular Sciences. 2024; 25(2):1170.
https://doi.org/10.3390/ijms25021170
Chicago/Turabian Style
Galadima, Makchit, Mariana Teles, Josep Pastor, Javier Hernández-Losa, Joan Enric RodrÃguez-Gil, and Maria Montserrat Rivera del Alamo.
2024. "Programmed Death-Ligand (PD-L1), Epidermal Growth Factor (EGF), Relaxin, and Matrix Metalloproteinase-3 (MMP3): Potential Biomarkers of Malignancy in Canine Mammary Neoplasia" International Journal of Molecular Sciences 25, no. 2: 1170.
https://doi.org/10.3390/ijms25021170
APA Style
Galadima, M., Teles, M., Pastor, J., Hernández-Losa, J., RodrÃguez-Gil, J. E., & Rivera del Alamo, M. M.
(2024). Programmed Death-Ligand (PD-L1), Epidermal Growth Factor (EGF), Relaxin, and Matrix Metalloproteinase-3 (MMP3): Potential Biomarkers of Malignancy in Canine Mammary Neoplasia. International Journal of Molecular Sciences, 25(2), 1170.
https://doi.org/10.3390/ijms25021170
